Midterm Mortality between Single or Multiple Exposure to Paclitaxel Coated Devices for the Treatment of Femoropopliteal Artery Disease

Eur J Vasc Endovasc Surg. 2022 Mar;63(3):521-522. doi: 10.1016/j.ejvs.2021.09.027. Epub 2021 Nov 24.
No abstract available

Keywords: Femoropopliteal; Mortality; Paclitaxel.

Publication types

  • Letter
  • Comment

MeSH terms

  • Femoral Artery* / surgery
  • Humans
  • Paclitaxel* / adverse effects
  • Popliteal Artery / surgery

Substances

  • Paclitaxel